| Identification of autoantibody-negative autoimmune type 2 diabetic patients BM Brooks-Worrell, JL Reichow, A Goel, H Ismail, JP Palmer Diabetes care 34 (1), 168-173, 2011 | 103 | 2011 |
| β Cell dysfunction exists more than 5 years before type 1 diabetes diagnosis C Evans-Molina, EK Sims, LA DiMeglio, HM Ismail, AK Steck, JP Palmer, ... JCI insight 3 (15), 2018 | 69 | 2018 |
| A randomized clinical trial assessing continuous glucose monitoring (CGM) use with standardized education with or without a family behavioral intervention compared with … Diabetes Care 44 (2), 464-472, 2021 | 48 | 2021 |
| Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trial J Ware, CK Boughton, JM Allen, ME Wilinska, M Tauschmann, L Denvir, ... The Lancet Digital Health 4 (4), e245-e255, 2022 | 46 | 2022 |
| The shape of the glucose response curve during an oral glucose tolerance test: forerunner of heightened glycemic failure rates and accelerated decline in β-cell function in TODAY S Arslanian, L El Ghormli, J Young Kim, F Bacha, C Chan, HM Ismail, ... Diabetes Care 42 (1), 164-172, 2019 | 45 | 2019 |
| Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine DK Tobias, J Merino, A Ahmad, C Aiken, JL Benham, D Bodhini, AL Clark, ... Nature medicine 29 (10), 2438-2457, 2023 | 39 | 2023 |
| The shape of the glucose concentration curve during an oral glucose tolerance test predicts risk for type 1 diabetes HM Ismail, P Xu, IM Libman, DJ Becker, JB Marks, JS Skyler, JP Palmer, ... Diabetologia 61 (1), 84-92, 2018 | 35 | 2018 |
| The influence of body mass index and age on C‐peptide at the diagnosis of type 1 diabetes in children who participated in the diabetes prevention trial‐type 1 JM Sosenko, S Geyer, JS Skyler, LE Rafkin, HM Ismail, IM Libman, YF Liu, ... Pediatric diabetes 19 (3), 403-409, 2018 | 27 | 2018 |
| Evaluation of short stature in children H Ismail, K Ness Pediatric Annals 42 (11), e227-e232, 2013 | 23 | 2013 |
| Self-rated health and factors influencing responses among young Egyptian type 1 diabetes patients H Ismail BMC public health 11, 1-7, 2011 | 23 | 2011 |
| ISPAD Clinical Practice Consensus Guidelines 2022: Management of cystic fibrosis‐related diabetes in children and adolescents KL Ode, M Ballman, A Battezzati, A Brennan, CL Chan, S Hameed, ... Pediatric diabetes 23 (8), 1212, 2022 | 21 | 2022 |
| Glycogen storage disease type III presenting with secondary diabetes and managed with insulin: a case report H Ismail Cases Journal 2, 1-4, 2009 | 20 | 2009 |
| One-hour oral glucose tolerance tests for the prediction and diagnostic surveillance of type 1 diabetes KM Simmons, JM Sosenko, M Warnock, S Geyer, HM Ismail, ... The Journal of Clinical Endocrinology & Metabolism 105 (11), e4094-e4101, 2020 | 18 | 2020 |
| Index60 identifies individuals at appreciable risk for stage 3 among an autoantibody-positive population with normal 2-hour glucose levels: implications for current staging … BM Nathan, MJ Redondo, H Ismail, L Jacobsen, EK Sims, J Palmer, ... Diabetes care 45 (2), 311-318, 2022 | 17 | 2022 |
| The pathological evolution of glucose response curves during the progression to type 1 diabetes in the TrialNet Pathway to Prevention Study HM Ismail, MA Cleves, P Xu, IM Libman, DJ Becker, JB Marks, JS Skyler, ... Diabetes Care 43 (11), 2668-2674, 2020 | 12 | 2020 |
| Comparative effects of glucose-lowering medications on kidney outcomes in type 2 diabetes: the GRADE randomized clinical trial DJ Wexler, IH De Boer, A Ghosh, N Younes, I Bebu, SE Inzucchi, ... JAMA internal medicine 183 (7), 705-714, 2023 | 9 | 2023 |
| COVID-19 pandemic effects on caregivers of youth with type 1 diabetes: Stress and self-efficacy HM Ismail, BL Hand, LA DiMeglio, R Oyetoro, PY Soni, J Adams, ... Diabetes Spectrum 35 (4), 461-468, 2022 | 7 | 2022 |
| Does the gut microbiome play a role in obesity in type 1 diabetes? Unanswered questions and review of the literature HM Ismail, C Evans-Molina Frontiers in Cellular and Infection Microbiology 12, 892291, 2022 | 7 | 2022 |
| Time to peak glucose and peak C-peptide during the progression to type 1 diabetes in the diabetes prevention trial and TrialNet cohorts MG Voss, DD Cuthbertson, MM Cleves, P Xu, C Evans-Molina, JP Palmer, ... Diabetes care 44 (10), 2329-2336, 2021 | 7 | 2021 |
| " T Cell-Positive Antibody-Negative" Phenotypic Type 2 Patients, a Unique Subgroup of Autoimmune Diabetes. HM Ismail, M Wotring, C Kimmie, L Au, JP Palmer, B Brooks-Worrell Diabetes 56, 2007 | 7 | 2007 |
